A. Ougolkov

发表

Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents.

A. Kozikowski, Rong L He, Yufeng Chen, 2010, Journal of medicinal chemistry.

Long-Term Survival and Prognostic Indicators in Small (2 cm) Pancreatic Cancer

W. Bamlet, G. Petersen, T. Smyrk, 2008 .

Long-Term Survival and Prognostic Indicators in Small (≤2 cm) Pancreatic Cancer

W. Bamlet, M. de Andrade, G. Petersen, 2008, Pancreatology.

Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.

T. Minamoto, M. Mai, A. Ougolkov, 2002, Gastroenterology.

Abnormal expression of E-cadherin, β-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis

V. Bilim, T. Minamoto, M. Mai, 2003, International Journal of Colorectal Disease.

in chronic lymphocytic leukemia B cells B target genes and induction of apoptosis κ silencing of nuclear factor Inhibition of glycogen synthase kinase-3 activity leads to epigenetic

N. Kay, M. Fernández-Zapico, A. Ougolkov, 2011 .

From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.

A. Kozikowski, I. Gaisina, A. Ougolkov, 2009, Journal of medicinal chemistry.

Inhibition of glycogen synthase kinase-3.

A. Ougolkov, D. Billadeau, 2008, Methods in molecular biology.

Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells.

N. Kay, M. Fernández-Zapico, A. Ougolkov, 2007, Blood.

Aberrant Nuclear Accumulation of Glycogen Synthase Kinase-3β in Human Pancreatic Cancer: Association with Kinase Activity and Tumor Dedifferentiation

T. Smyrk, S. Chari, V. Bilim, 2006, Clinical Cancer Research.

Glycogen Synthase Kinase-3 B Participates in Nuclear Factor K B – Mediated Gene Transcription and Cell Survival in Pancreatic Cancer Cells

R. Urrutia, M. Fernández-Zapico, A. Ougolkov, 2005 .

Glycogen Synthase Kinase-3β Participates in Nuclear Factor κB–Mediated Gene Transcription and Cell Survival in Pancreatic Cancer Cells

R. Urrutia, M. Fernández-Zapico, A. Ougolkov, 2005 .

CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.

S. Fuchs, T. Minamoto, N. Bhatia, 2006, Nature.

Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer.

S. Fuchs, V. Bilim, T. Minamoto, 2004, Journal of the National Cancer Institute.

Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.

R. Urrutia, M. Fernández-Zapico, A. Ougolkov, 2005, Cancer research.

(cid:1) -Catenin and ras Oncogenes Detect Most Human Colorectal Cancer 1

T. Minamoto, M. Mai, A. Ougolkov, 2003 .

Associations Among (cid:2) -TrCP, an E3 Ubiquitin Ligase Receptor, (cid:2) -Catenin, and NF- (cid:3) B in Colorectal Cancer

V. Bilim, T. Minamoto, A. Ougolkov, 2004 .

GSK-3 IS A POTENTIAL THERAPEUTIC TARGET FOR THE TREATMENT OF RENAL CELL CARCINOMA (RCC): PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION

M. Oya, V. Bilim, Y. Tomita, 2009 .

Inhibition of GSK-3 Induces Apoptosis of CLL Cells by Abrogating NFkB Nuclear Activity.

N. Kay, A. Ougolkov, D. Billadeau, 2006 .

Inhibition of GSK-3 Activity Leads to Epigenetic Silencing of NF κ B Target Genes and Induction of Apoptosis in CLL B-Cells

N. Kay, M. Fernández-Zapico, A. Ougolkov, 2007 .

Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells.

N. Kay, M. Fernández-Zapico, A. Ougolkov, 2007, Blood.

Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation.

Bin Zhang, Zhi-wei Yu, T. Minamoto, 2005, Biochemical and biophysical research communications.

Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis.

John R. Goodell, D. Ferguson, A. Ougolkov, 2008, Journal of medicinal chemistry.

CRD-BP mediates stabilization of βTrCP1 and c-myc mRNA in response to β-catenin signalling

S. Fuchs, T. Minamoto, N. Bhatia, 2006, Nature.

Associations among β-TrCP, an E3 ubiquitin ligase receptor, β-catenin, and NF-κB in colorectal cancer

S. Fuchs, V. Bilim, T. Minamoto, 2004 .

Oncogenic β-Catenin Signaling Networks in Colorectal Cancer

S. Fuchs, T. Minamoto, A. Ougolkov, 2005, Cell cycle.

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma

M. Oya, V. Bilim, Y. Tomita, 2009, British Journal of Cancer.

Targeting GSK-3: a promising approach for cancer therapy?

A. Ougolkov, D. Billadeau, 2006, Future oncology.

Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2

V. Bilim, A. Ougolkov, D. Billadeau, 2008, Clinical Cancer Research.

Deregulated GSK3β activity in colorectal cancer: its association with tumor cell survival and proliferation

Z. Yu, T. Minamoto, M. Mai, 2006 .

Contents Vol. 8, 2008

Wang Chi Cheung, M. Boermeester, N. Malats, 2008, Pancreatology.

Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.

John R. Goodell, D. Ferguson, A. Ougolkov, 2009, European journal of pharmacology.

Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling

T. Minamoto, M. Mai, A. Ougolkov, 2002, Expert review of molecular diagnostics.

β-catenin and ras oncogenes detect most human colorectal cancer

T. Minamoto, M. Mai, Bin Zhang, 2003 .

Adjuvant Immunochemotherapy with Protein-Bound Polysaccharide K for Colon Cancer in Relation to Oncogenic β-Catenin Activation

Y. Ohashi, T. Minamoto, M. Mai, 2007, Diseases of the colon and rectum.

Adjuvant Immunochemotherapy with Protein-Bound Polysaccharide K for Colon Cancer in Relation to Oncogenic β-Catenin Activation

Y. Ohashi, T. Minamoto, M. Mai, 2007 .

Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.

A. Shimizu, V. Bilim, T. Minamoto, 2000, Journal of experimental & clinical cancer research : CR.

Long-Term Survival and Prognostic Indicators in Small (≤2 cm) Pancreatic Cancer

W. Bamlet, M. de Andrade, T. Smyrk, 2008, Pancreatology.